Radiotherapy provider Varian Medical Systems has treated its first patient with its Gated RapidArc system, a radiotherapy treatment technology that monitors patient breathing and compensates for tumor motion.
The combination of FDG PET/CT and circulating tumor cell (CTC) counts might be a useful tool to monitor response to therapy in breast cancer patients, according to a study published in this month's Journal of Nuclear Medicine.
Immunomedics and GE Healthcare have entered into a license and collaboration agreement for the evaluation of labeling technologies based on Immunomedics' patented F-18 peptide labeling method.
The Centers for Medicare & Medicaid Services (CMS) has issued a decision memo stating that the national coverage determination manual will be changed to remove the current absolute restriction of coverage to ‘only one’ FDG PET scan, and local Medicare administrative contractors will have discretion to cover (or not cover) any additional FDG PET scan for initial treatment strategy in solid tumors and myeloma.
The American Society for Radiation Oncology (ASTRO) has released evidence-based guidelines supporting the use of hypofractionated (HF) whole breast irradiation (WBI) for certain patients with early-stage breast cancer, based on the findings of a study published in the August edition of the International Journal of Radiation, Oncology, Biology and Physics.
Age-specific differences in mammographic screening can contribute to lower detectability and differences in tumor growth rates, according to a study published online July 27 in the Journal of the National Cancer Institute.
PHILADELPHIA--A new mathematical model to better pinpoint tumor location and thereby reduce radiation exposure uses data on how tumor motion has changed during a course of radiation treatment, along with real-time tumor images to calculate the confidence physicists can have about an instantaneous tumor position estimate. The research was presented July 21 at the annual meeting of the American Association of Physicists in Medicine (AAPM).
Adding concurrent-adjuvant chemotherapy to radiation therapy can reduce cancer-specific deaths, but increases acute toxicity for nasopharyngeal carcinoma patients, according to a study published online July 15 in the Journal of the National Cancer Institute.
FDG PET/CT may have a potential role in asymptomatic breast cancer patients with rising markers and negative conventional imaging, according to a multicenter study published May 21 ahead of print in the European Journal of Radiology.
The multichannel single-entry brachytherapy device, the Strut-Adjusted Volume Implant, can safely allow an increase in eligibility for accelerated partial-breast irradiation compared to balloon brachytherapy or 3D conformal radiation, according to a study published June 18 in the International Journal of Radiation Oncology, Biology and Physics.
Breast imaging technology developer Imaging Diagnostic Systems (IDS) has installed its CT Laser Mammography system at Tata Memorial Hospital in Mumbai, India.
Endoscopic ultrasound evaluation in patients with locoregional pancreatic cancer can be associated with improved outcomes and may aid earlier detection, according to a study published in the July issue of Gastrointestinal Endoscopy.
Developing new imaging biomarkers and public data sets for lung cancer is important for independent peer review and verification of results, and new capabilities for the rapid assessment of treatment responses are required in order to allow for more rapid evaluation of the success or failure of drug candidates in clinical trials, according to a report published July in Optics Express.
An optical imaging technique, Cerenkov luminescence imaging, shows excellent promise as a potential new method for rapid, high-throughput screening of radiopharmaceuticals, said a study published in the July issue of the Journal of Nuclear Medicine.
Written by Gina Narcisi
As an adjunct therapy to ultrasound and mammography, near-infrared (NIR) optical tomography can serve as a safe, quick and noninvasive method that may aid in the accurate diagnosis of small indeterminate breast lesions, according to research published June 22 in Radiology.
Elekta has launched Monaco treatment planning system, version 2.03, designed to enhance planning for Elekta volumetric modulated arc therapy.
Oropharyngeal squamous cell carcinoma caused by human papillomavirus (HPV) is a strong and independent prognostic factor for survival among patients with oropharyngeal cancer, according to research from the Radiation Therapy Oncology Group (RTOG) published on June 7 in the New England Journal of Medicine and presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
A single dose of radiotherapy delivered at the time of surgery by way of targeted intraoperative radiotherapy should be considered as an alternative to external beam radiotherapy delivered over several weeks postsurgery for selected patients with early breast cancer, found a study published online June 5 in the Lancet.
Medical imaging core lab services provider Icon Medical Imaging has expanded its technology platform to expedite oncology clinical trials, incorporating RECIST (Response Evaluation Criteria In Solid Tumors) 1.1 evaluation criteria to its ICOSpeedRead system.
Major pathologic response to preoperative chemotherapy and radiation occurs in a minority of patients with pancreatic adenocarcinoma and is independently associated with prolonged survival, according to a study presented at the 46th annual meeting of the American Society of Clinical Oncology (ASCO) on June 6 in Chicago.
|